跳至主要内容
临床试验/ACTRN12620000691943
ACTRN12620000691943尚未招募1 期

The validation of human cerebral oxygenation sensitivity and reproducibility of a novel MR-based device under dynamic conditions in healthy humans

A/Prof. Shieak Tzeng0 个研究点目标入组 4 人开始时间: 2020年6月22日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
4

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • 18-50 years old
  • Generally healthy
  • Non-smoker
  • People with a BMI 18.5-30 kg m^-2

排除标准

  • History of migraines
  • History of respiratory or cardiovascular disease or specific renal impairment.
  • Currently taking diuretics, antacids, proton pump inhibitors, or histamine blockers.
  • Under 18 or over 50 years of age
  • History of stroke or other neurological conditions
  • A contrast enhanced medical scan in the past week
  • There will also be a set of within-trial cessation criteria: a resting heart rate above 140 bpm, a peripheral O2 saturation below 70%, subject intolerance or request, sudden headache or nausea, or mental abnormalities as assessed by a clinician (i.e.: confusion, incoordination of motor skills).

研究者

发起方
A/Prof. Shieak Tzeng

相似试验